Open AccessCase Report of Prostate Cancer Patient with Only Lymph Node Involvement on F-18 FDG PET/CT
Author(s) -
Hyun Jin Jung,
Sungmin Kang
Publication year - 2018
Publication title -
gosin daehakgyo uigwa daehak haksulji/kosin medical journal
Language(s) - English
Resource type - Journals
eISSN - 2586-7024
pISSN - 2005-9531
DOI - 10.7180/kmj.2018.33.3.391
Subject(s) - medicine , prostate cancer , dysuria , hypermetabolism , lymph node , radiology , lymph , pet ct , prostate , bone metastasis , metastasis , nuclear medicine , urology , cancer , positron emission tomography , pathology , urinary system
We report a case of a patient with locally advanced prostate cancer who had only lymph node involvement without bone metastasis on F-18 FDG PET/CT. A 62-year-old Korean male was admitted to our hospital due to dysuria. His PSA level on admission was 79.35 ng/mL. A transrectal ultrasound-guided prostate biopsy confirmed prostate cancer and his Gleason score was 10 (5+5). F-18 FDG PET/CT demonstrated a hypermetabolic mass lesion with SUVmax 7.0 in the prostate and hypermetabolism with SUVmax 4.7 of the abdominal and pelvic lymph nodes. Tc-99m HDP bone scan showed no significant bone metastasis. The patient underwent hormonal therapy for 9 months. Follow-up F-18 FDG PET/CT showed significantly reduced size and FDG uptake in the prostate and abdominal and pelvic lymph nodes. In this case, treatment monitoring with F-18 FDG PET/CT showed decreased mass size and FDG uptake in the prostate and abdominal and pelvic lymph nodes.